Jiangsu Nanfang Medical Co. (603880.SH) announced that the company planned to acquire a 70 percent stake in Jinagsu Vanguard Pharmaceutical Co. for about 1.05 billion yuan by share issue, the Xinhua-run Shanghai Securities News reported on July 6.
Founded in 2003, Jiangsu Vanguard Pharmaceutical Co, is mainly engaged in the R&D, production and sales of chemical and Chinese herb medicines, focusing on the field of chronic diseases, such as cardiovascular disease, hyperglycemia, anti-tumor, etc.
Founded in 2003, Jiangsu Vanguard Pharmaceutical Co, is mainly engaged in the R&D, production and sales of chemical and Chinese herb medicines, focusing on the field of chronic diseases, such as cardiovascular disease, hyperglycemia, anti-tumor, etc.
Latest comments